Beijing, China--(BUSINESS WIRE)--September 1, 2009- -Hundreds of Western and East Asian clinical development executives from the pharmaceutical, biotech, and CRO industry will gather on November 8-10 in Beijing to attend the industry's largest annual international conference covering China's booming clinical development industry.
"CHINA TRIALS 2009: Global Clinical Development Summit" will feature insights from small and emerging biotech/pharma companies that have successfully outsourced trials to China, who will share their strategies on selecting CROs in China as well as their experiences with the quality and acceptability of submitting the data to Western health authorities. Big pharma companies already in China will discuss strategies to refine and improve their clinical operations and interactions with the SFDA, China's health authority. While most of the presentations will be given in English, the entire conference will be translated simultaneously in English and Mandarin.
Conference topics include:
-Integrating China into global clinical development
-Regulatory review at the SFDA
-Successful global collaborations between Pharma, Biotechs and CROs
-Regional Asia-Pacific Drug Development
-Oncology, neuroscience, vaccine, biologics and medical device development
-Safety assessment for conducting trials in China
-Conducting early-stage trials in China
An international speaking faculty of over 75 speakers from over 40 pharma and biotech companies includes Amgen, Baxter, Bayer, Biogen Idec, Bristol-Myers Squibb, Celgene, Daiichi-Sankyo, GlaxoSmithKline, Johnson & Johnson, Merck, Neuromed, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi-Aventis, Schering-Plough, Wyeth and many more.
All the major players from the CRO and clinical service provider industry will be in attendance including Quintiles, Covance, Parexel Apex, RPS, i3 Research, Excel Pharmastudies, TigerMed, Fountain Medical Development, Zuellig Pharma, George Clinical, Phase Forward, Fisher Clinical Services, and more.
The conference agenda and registration information can be found by visiting the conference website at www.chinatrialsevent.com. Some speaking opportunities remain and sponsorship/exhibition opportunities are still available. To explore these opportunities further, please contact the organizer Jon E. Liong at jon.liong@lycheegroup.com or call 86-21-6171-1654.